[AAAS] Preclinical, randomized phase 1, and compassionate use evaluation of REGN4461, a leptin receptor agonist antibody for leptin deficiency

xiaofangwen Post time 2024-4-20 09:17:55 | Show all posts |Read mode
Reward10points

journal£ºScience Translational Medicine

Authors£ºJudith Y. Altarejos; Jeffrey Pangilinan; Simona Podgrabinska; Baris Akinci; Maria Foss-Freitas; Adam H. Neidert; Yonaton Ray; Wenjun Zheng; Steven Kim; Vishal Kamat; Meilin Huang; Soo Min; Jason Mastaitis; Giselle Dominguez-Gutierrez; Jee-Hae Kim; Panayiotis Stevis; Tammy Huang; Brian Zambrowicz; William C. Olson; Stephen Godin; Elizabeth Bradley; Andrew D. Gewitz; Mark Baker; Rita Hench; Matthew S. Davenport; Thomas L. Chenevert; Frank DiPaola; George D. Yancopoulos; Andrew J. Murphy; Gary A. Herman; Bret J. Musser; Hayes Dansky; Joyce Harp; Jesper Gromada; Mark W. Sleeman; Elif A. Oral; Benjamin A. Olenchock

Published date£º2023-11-22

DOI£º10.1126/scitranslmed.add4897

PDF link£ºhttps://www.science.org/doi/pdf/10.1126/scitranslmed.add4897

Article link£ºhttp://dx.doi.org/10.1126/scitranslmed.add4897

Article Source£ºAmerican Association for the Advancement of Science (AAAS)¡£


Remark£º

Best Answer

Please adopt

View Full Content

Reply

Use magic Donate Report

All Reply1 Show all posts
zpsukhan Post time 2024-4-20 09:17:56 | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report

Senior Member
  • post

  • reply

  • points

    1320

Latest Reply

Return to the list